Nationwide registry‐based trial of risk‐stratified cervical screening

Laila Sara Arroyo Mühr(Karolinska Institutet), Joakim Dillner(Malmö University), Jiangrong Wang(Shandong First Medical University), Emel Yılmaz(Karolinska Institutet), Miriam Elfström(Karolinska Institutet), Sadaf Hassan(Karolinska Institutet)

International Journal of Cancer

August 15, 2024

10.1002/ijc.35142

Cited by 7

Related Papers

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

|BMJ|2008|630

Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

|Vaccine|2006|545

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types

|Virology|2013|317

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

|Nature Reviews Clinical Oncology|2018|173

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

|BMJ|2014|140